🇺🇸 FDA
Pipeline program

Phase I Study of PM534 to Patients with Advanced Solid Tumors

PM534-A-002-24

Phase 2 other active

Quick answer

Phase I Study of PM534 to Patients with Advanced Solid Tumors for Advances solid tumors is a Phase 2 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Advances solid tumors
Phase
Phase 2
Modality
other
Status
active

Clinical trials